GHRP-6 Acetate Research Information
Growth Hormone-Releasing Peptide-6
For Pulsatile Growth Hormone Research
️ Important: This information is for educational and research purposes only. Always consult with a qualified healthcare professional before use.
Contents
What is GHRP-6 Acetate?
GHRP-6 (Growth Hormone-Releasing Peptide-6) is a synthetic hexapeptide (His-D-Trp-Ala-Trp-D-Phe-Lys-NH2) that acts as a potent growth hormone secretagogue receptor (GHSR) agonist . It was one of the first growth hormone-releasing peptides developed and has been widely studied for its ability to stimulate endogenous GH release in a pulsatile manner .
GHRP-6 has been extensively researched since the 1980s and is considered a first-generation GHRP . It is a potent GH secretagogue that also has effects on appetite and gastric motility . GHRP-6 is available in pen and freeze-dried vial formulations for research purposes.
How GHRP-6 Works
GHRP-6 works through a targeted mechanism to stimulate natural growth hormone release:
GHSR Agonist
Binds to growth hormone secretagogue receptor (GHSR) on pituitary somatotroph cells
Pulsatile GH Release
Stimulates natural pulsatile growth hormone secretion pattern
Appetite Stimulation
Increases appetite and gastric motility due to ghrelin mimicry
GHRP-6 is often combined with a GHRH analog (such as CJC-1295 or Sermorelin) for enhanced synergistic GH release .
Research Applications
Growth Hormone Research
Studying pulsatile GH secretion and IGF-1 elevation
Muscle & Recovery
Researching muscle growth, recovery, and protein synthesis
Metabolic Research
Investigating appetite, gastric motility, and energy balance
Combination Research
Synergistic effects with GHRH analogs (CJC-1295, Sermorelin)
Clinical Studies
Growth Hormone Secretagogue Activity
- GHRP-6 is a potent GH secretagogue that was first identified in the 1980s
- Stimulates pulsatile GH release through the GHSR pathway
- Effective in both oral and injectable forms in research settings
Appetite & Gastric Effects
- GHRP-6 mimics ghrelin and stimulates appetite
- Increases gastric motility and enhances food intake
- Effects are mediated through the GHSR in the hypothalamus
Combination Therapy
- When combined with GHRH analogs, GHRP-6 shows enhanced synergistic GH release
- Commonly stacked with CJC-1295 or Sermorelin for research purposes
- Preserves natural pulsatile GH secretion patterns
Interactive Dosing Guide
Select your vial size and dose to see the corresponding volume, clicks, dosing frequency, and how many doses per vial:
️ Step 1: Select Your Vial Size
Step 2: Select Your Dose
Common research protocols: 50-300 mcg per injection, 1-3 times daily
Vial Size
10mg Vial
Selected Dose
100 mcg
Doses per Vial
100 doses
Pen Clicks
3 clicks
Volume
0.03 mL
Protocol Level
Level 2 (Standard)
Recommended Schedule
1-3 times daily - Pulsatile Protocol
️ Do not change your dose unless advised by a qualified professional.
Protocol Level Summary
Based on research protocols: 50-300 mcg per injection, 1-3 times daily.
| Protocol Level | Target Dose | Frequency | Pen Clicks | Volume (mL) | Who It\'s For |
|---|---|---|---|---|---|
| Level 1 (Starting) | 50 mcg | 1-3x daily | 1.5 clicks | 0.015 mL | New users, first 2 weeks |
| Level 2 (Standard) | 100 mcg | 1-3x daily | 3 clicks | 0.03 mL | After 2 weeks, maintenance |
| Level 3 (Advanced) | 150-200 mcg | 1-3x daily | 4.5-6 clicks | 0.045-0.06 mL | If more response needed |
| Level 4 (Maximum) | 300 mcg | 1-3x daily | 9 clicks | 0.09 mL | Experienced users only |
️ Do not change your dose unless advised by a qualified professional.
Vial Users (Insulin Syringe)
Add 3mL of bacteriostatic water to your freeze-dried vial and mix gently. After reconstitution, use the table below to draw your dose:
Vial Size
10mg vial with 3mL bac water
| Dose | Frequency | Units on Syringe | Volume (mL) | Protocol Level |
|---|
️ Always use a new sterile needle and syringe for each injection.
️ Safety & Precautions
GHRP-6 is generally well-tolerated at recommended doses. However, it has a more pronounced effect on appetite compared to other GHRPs.
- Injection site reactions: Mild redness, tenderness, or pain at injection site
- Increased hunger: Pronounced appetite stimulation due to ghrelin mimicry
- Flushing or headache: Occasional and mild
- Nausea: Rare, especially at higher doses
Important Safety Considerations:
- GHRP-6 is not FDA-approved for any indication
- Human data is limited; most research is preclinical
- Do not use if allergic to GHRP-6 or any ingredients
- Do not use if pregnant or breastfeeding
️ Warning: GHRP-6 is an investigational peptide with limited human safety data. If you experience severe allergic reactions, difficulty breathing, or signs of anaphylaxis, seek immediate medical help.
References
- GHRP-6 Research Overview. Peptide Sciences.
- GHRP-6 Technical Guide. Benchchem.
- GHRP-6: A First-Generation Growth Hormone Secretagogue. Journal of Peptide Research.
This information is for educational and research purposes only. Always consult with a qualified healthcare professional.
Last updated: July 2026